Article Text

Download PDFPDF
Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome
  1. H S Schaaf1,
  2. K Shean2,
  3. P R Donald1
  1. 1Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University and Tygerberg Children’s Hospital, South Africa
  2. 2Brooklyn Hospital for Chest Diseases, Western Cape Province, South Africa
  1. Correspondence to:
    Dr H S Schaaf
    Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, PO Box 19063, Tygerberg 7505, South Africa; hsssun.ac.za

Abstract

Aims: To determine the delay in diagnosis of multidrug resistant (MDR) tuberculosis (TB), the correlation between drug susceptibility patterns of adult-child contact pairs, the effectiveness of treatment, and the outcome in these children.

Methods: MDR M tuberculosis culture results of children were prospectively collected during a four year period in the Western Cape Province of South Africa, an area with a TB incidence of 589/100 000 population, and a new MDR TB rate of 0.94%. Folder reviews were done to retrieve clinical information. Children not already on treatment at our MDR TB clinic or TB hospital were recalled and appropriate treatment was started. Follow up was done for as long as possible.

Results: Thirty nine children, median age 4.5 years at first TB diagnosis and 6.2 years on MDR culture confirmation, were seen. Delay in starting appropriate MDR treatment after TB diagnosis was a median of 2 days if MDR TB source cases were taken into account, but 246 days if the drug susceptibility pattern of the source case was not considered, and 283 days if there was no known tuberculosis source case. Correlation between the drug susceptibility results of the child’s and adult source case’s isolates was 68%. Seventeen children had smear positive tuberculosis, of whom 13 had cavitatory pulmonary disease. Eight children had central nervous system TB. Thirty six children were treated for MDR tuberculosis, of whom four died.

Conclusions: Obtaining a detailed contact history is essential as a delay in starting appropriate MDR antituberculosis treatment has potentially serious consequences.

  • Mycobacterium tuberculosis
  • multidrug resistant
  • delay
  • outcome
  • treatment
  • AFB, acid fast bacilli
  • DOT, directly observed treatment
  • DSP, drug susceptibility pattern
  • INH, isoniazid
  • MDR, multidrug resistant
  • RFLP, restriction fragment length polymorphism
  • RMP, rifampicin
  • TB, tuberculosis
  • TBM, tuberculous meningitis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes